10 August 2021 | News
A patented AG+ five-stage sterilisation purifying technology
Aurabeat, US FDA approved anti-Covid Class 2 medical device for SARS-COV-2 disinfection, has been launched in the Indian market. Hong Kong-based Aurabeat has developed the patented AG+ five-stage sterilisation purifying technology after extensive research in the field of air filtration for over a decade.
Aurabeat’s AG+ Pro Silver Ion Antiviral Air Purifier cleans the air up to 3.4 times in one hour while actively eliminating bacteria and viruses from air and surfaces.
Apart from US FDA, the product is certified by MRI Global, ATCC (American Type Culture Collection), SGS (General Society of Surveillance-Geneva), FC, CE, ISO, UL, RoHS, UKRI Medical Research Council, CEN European Committee for Standardization. Aurabeat is used in over 200 hospitals, 200+ schools protecting the air from COVID-19 in more than 40 countries.
According to the actual experimental test results using COVID-19 viruses in a US virology laboratory, MRI Global, Aurabeat AG+ Silver ion Antiviral air purifier proved to effectively eliminate 99.9 per cent COVID-19 in 15 minutes. Other experimental tests have also proven that Aurabeat AG+ silver ion air sterilisation purifying technology can kill 99.9 per cent influenza viruses, fungi staphylococcus aureus and E.coli.